Orthotopic model of ovarian cancer

Alessandra Decio, Raffaella Giavazzi

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Citations (Scopus)

Abstract

Epithelial ovarian cancer (EOC) is the fifth commonest cancer-related cause of female death in the developed world. In spite of current surgical and chemotherapeutic options the vast majority of patients have widely metastatic disease and the survival rate has not much changed over the last years. The anti- angiogenic drugs are driving the field of agents targeting the tumor microenvironment in ovarian cancer. Preclinical models that accurately reproduce the molecular and biological features of ovarian cancer patients are a valuable means of producing reliable data on personalized medicine and predicting the therapeutic response in clinical trials. In this methodological chapter we describe the orthotopic model of ovarian cancer implanted under the ovarian bursa of mice. In spite of anatomical differences between the rodent and human bursa-fallopian tube, the appropriate primary tumor microenvironment at the site of the implant allows investigation of tumor–stroma interactions (e.g., angiogenesis), and is well suited for studying the tumor dissemination and metastasis typical of this disease. This model—although fairly labor intensive—may be useful for assessing novel, more selective therapeutic interventions and for biomarker discovery, reflecting the behavior of this disease.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages139-149
Number of pages11
Volume1464
DOIs
Publication statusPublished - 2016

Publication series

NameMethods in Molecular Biology
Volume1464
ISSN (Print)10643745

Fingerprint

Ovarian Neoplasms
Tumor Microenvironment
Precision Medicine
Angiogenesis Inhibitors
Fallopian Tubes
Cause of Death
Rodentia
Neoplasms
Survival Rate
Biomarkers
Clinical Trials
Neoplasm Metastasis
Therapeutics
Ovarian epithelial cancer

Keywords

  • Angiogenesis
  • Intrabursal transplant
  • Metastasis
  • Optical imaging
  • Orthotopic transplant
  • Ovarian cancer
  • Ovarian cancer cell lines
  • Patient-derived xenografts

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Decio, A., & Giavazzi, R. (2016). Orthotopic model of ovarian cancer. In Methods in Molecular Biology (Vol. 1464, pp. 139-149). (Methods in Molecular Biology; Vol. 1464). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-3999-2_13

Orthotopic model of ovarian cancer. / Decio, Alessandra; Giavazzi, Raffaella.

Methods in Molecular Biology. Vol. 1464 Humana Press Inc., 2016. p. 139-149 (Methods in Molecular Biology; Vol. 1464).

Research output: Chapter in Book/Report/Conference proceedingChapter

Decio, A & Giavazzi, R 2016, Orthotopic model of ovarian cancer. in Methods in Molecular Biology. vol. 1464, Methods in Molecular Biology, vol. 1464, Humana Press Inc., pp. 139-149. https://doi.org/10.1007/978-1-4939-3999-2_13
Decio A, Giavazzi R. Orthotopic model of ovarian cancer. In Methods in Molecular Biology. Vol. 1464. Humana Press Inc. 2016. p. 139-149. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-3999-2_13
Decio, Alessandra ; Giavazzi, Raffaella. / Orthotopic model of ovarian cancer. Methods in Molecular Biology. Vol. 1464 Humana Press Inc., 2016. pp. 139-149 (Methods in Molecular Biology).
@inbook{72e3eea80a674cca9aaed4e9a3a62ea8,
title = "Orthotopic model of ovarian cancer",
abstract = "Epithelial ovarian cancer (EOC) is the fifth commonest cancer-related cause of female death in the developed world. In spite of current surgical and chemotherapeutic options the vast majority of patients have widely metastatic disease and the survival rate has not much changed over the last years. The anti- angiogenic drugs are driving the field of agents targeting the tumor microenvironment in ovarian cancer. Preclinical models that accurately reproduce the molecular and biological features of ovarian cancer patients are a valuable means of producing reliable data on personalized medicine and predicting the therapeutic response in clinical trials. In this methodological chapter we describe the orthotopic model of ovarian cancer implanted under the ovarian bursa of mice. In spite of anatomical differences between the rodent and human bursa-fallopian tube, the appropriate primary tumor microenvironment at the site of the implant allows investigation of tumor–stroma interactions (e.g., angiogenesis), and is well suited for studying the tumor dissemination and metastasis typical of this disease. This model—although fairly labor intensive—may be useful for assessing novel, more selective therapeutic interventions and for biomarker discovery, reflecting the behavior of this disease.",
keywords = "Angiogenesis, Intrabursal transplant, Metastasis, Optical imaging, Orthotopic transplant, Ovarian cancer, Ovarian cancer cell lines, Patient-derived xenografts",
author = "Alessandra Decio and Raffaella Giavazzi",
year = "2016",
doi = "10.1007/978-1-4939-3999-2_13",
language = "English",
volume = "1464",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "139--149",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Orthotopic model of ovarian cancer

AU - Decio, Alessandra

AU - Giavazzi, Raffaella

PY - 2016

Y1 - 2016

N2 - Epithelial ovarian cancer (EOC) is the fifth commonest cancer-related cause of female death in the developed world. In spite of current surgical and chemotherapeutic options the vast majority of patients have widely metastatic disease and the survival rate has not much changed over the last years. The anti- angiogenic drugs are driving the field of agents targeting the tumor microenvironment in ovarian cancer. Preclinical models that accurately reproduce the molecular and biological features of ovarian cancer patients are a valuable means of producing reliable data on personalized medicine and predicting the therapeutic response in clinical trials. In this methodological chapter we describe the orthotopic model of ovarian cancer implanted under the ovarian bursa of mice. In spite of anatomical differences between the rodent and human bursa-fallopian tube, the appropriate primary tumor microenvironment at the site of the implant allows investigation of tumor–stroma interactions (e.g., angiogenesis), and is well suited for studying the tumor dissemination and metastasis typical of this disease. This model—although fairly labor intensive—may be useful for assessing novel, more selective therapeutic interventions and for biomarker discovery, reflecting the behavior of this disease.

AB - Epithelial ovarian cancer (EOC) is the fifth commonest cancer-related cause of female death in the developed world. In spite of current surgical and chemotherapeutic options the vast majority of patients have widely metastatic disease and the survival rate has not much changed over the last years. The anti- angiogenic drugs are driving the field of agents targeting the tumor microenvironment in ovarian cancer. Preclinical models that accurately reproduce the molecular and biological features of ovarian cancer patients are a valuable means of producing reliable data on personalized medicine and predicting the therapeutic response in clinical trials. In this methodological chapter we describe the orthotopic model of ovarian cancer implanted under the ovarian bursa of mice. In spite of anatomical differences between the rodent and human bursa-fallopian tube, the appropriate primary tumor microenvironment at the site of the implant allows investigation of tumor–stroma interactions (e.g., angiogenesis), and is well suited for studying the tumor dissemination and metastasis typical of this disease. This model—although fairly labor intensive—may be useful for assessing novel, more selective therapeutic interventions and for biomarker discovery, reflecting the behavior of this disease.

KW - Angiogenesis

KW - Intrabursal transplant

KW - Metastasis

KW - Optical imaging

KW - Orthotopic transplant

KW - Ovarian cancer

KW - Ovarian cancer cell lines

KW - Patient-derived xenografts

UR - http://www.scopus.com/inward/record.url?scp=84995752447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995752447&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-3999-2_13

DO - 10.1007/978-1-4939-3999-2_13

M3 - Chapter

VL - 1464

T3 - Methods in Molecular Biology

SP - 139

EP - 149

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -